Details of the Drug

General Information of Drug (ID: DMLUZJR)

• Drug Name: KTE-C19 CAR-T cell therapy

Indication

Disease Entry	ICD 11	Status	REF
Mantle cell lymphoma	2A85.5	Phase 2	[1]

• Cross-matching ID: TTD ID: D0A4PJ

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)